We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
2601
DELISTED
Invacare Corporation
IVC
| $1.26M | ﹤0.01% |
139,963
-6,088
| -4% | -$51.2K |
|
2602
Simulations Plus
SLP
$371M
| $1.26M | ﹤0.01% |
43,281
-387
| -0.9% | -$13.1K |
|
2603
VSE Corp
VSEC
$6.12B
| $1.25M | ﹤0.01% |
32,999
-1,463
| -4% | -$54.4K |
|
|
OPTN
2604
DELISTED
OptiNose
OPTN
| $1.25M | ﹤0.01% |
9,059
+3,499
| +63% | +$454K |
|
|
EIGI
2605
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $1.25M | ﹤0.01% |
265,719
-2,701
| -1% | -$11.1K |
|
2606
Metallus
MTUS
$898M
| $1.25M | ﹤0.01% |
158,819
-9,558
| -6% | -$59.9K |
|
2607
Paysign
PAYS
$705M
| $1.25M | ﹤0.01% |
122,711
-307
| -0.2% | -$3.23K |
|
|
PROS
2608
DELISTED
ProSight Global, Inc.
PROS
| $1.24M | ﹤0.01% |
76,594
+38,270
| +100% | +$645K |
|
2609
Century Casinos
CNTY
$34M
| $1.23M | ﹤0.01% |
155,380
+18,351
| +13% | +$143K |
|
2610
SmartFinancial
SMBK
$888M
| $1.22M | ﹤0.01% |
51,607
+9,563
| +23% | +$210K |
|
2611
HCI Group
HCI
$2.41B
| $1.21M | ﹤0.01% |
26,582
-1,289
| -5% | -$56.8K |
|
2612
Alphatec Holdings
ATEC
$1.44B
| $1.21M | ﹤0.01% |
170,532
+60,298
| +55% | +$387K |
|
2613
Forum Energy Technologies
FET
$835M
| $1.21M | ﹤0.01% |
35,941
-19,588
| -35% | -$531K |
|
2614
Clarus
CLAR
$143M
| $1.21M | ﹤0.01% |
89,451
-29,832
| -25% | -$368K |
|
2615
RPC Inc
RES
$1.3B
| $1.21M | ﹤0.01% |
230,176
| – | – |
|
2616
Farmers & Merchants Bancorp
FMAO
$481M
| $1.2M | ﹤0.01% |
39,779
-156
| -0.4% | -$4.13K |
|
|
RRD
2617
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.2M | ﹤0.01% |
303,097
-15,100
| -5% | -$59.7K |
|
2618
Invesco Municipal Opportunity Trust
VMO
$663M
| $1.19M | ﹤0.01% |
88,572
| – | – |
|
2619
MasterCraft Boat Holdings
MCFT
$590M
| $1.18M | ﹤0.01% |
75,172
-169,945
| -69% | -$2.68M |
|
2620
Ituran Location and Control
ITRN
$1.05B
| $1.18M | ﹤0.01% |
47,067
-6,588
| -12% | -$161K |
|
2621
KRONOS Worldwide
KRO
$989M
| $1.18M | ﹤0.01% |
88,061
-5,551
| -6% | -$72.7K |
|
2622
Limoneira
LMNR
$251M
| $1.18M | ﹤0.01% |
61,308
| – | – |
|
2623
CorMedix
CRMD
$584M
| $1.18M | ﹤0.01% |
161,599
+100,158
| +163% | +$612K |
|
|
EBTC
2624
DELISTED
Enterprise Bancorp
EBTC
| $1.18M | ﹤0.01% |
34,732
-1,932
| -5% | -$59.8K |
|
|
EIGR
2625
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.18M | ﹤0.01% |
2,634
+645
| +32% | +$229K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.